Mohammed Nabil Quraishi

18PUBLICATIONS
16CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Tumour immunologyHaematological tumoursAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Oct 15, 2026
Real-World Effectiveness and Safety of Advanced Combination Treatment in Patients with Refractory Inflammatory Bowel Disease.

|Oct 07, 2026
Subcutaneous infliximab in inflammatory bowel disease: from pharmacokinetic principles to clinical practice.

|Oct 05, 2026
Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study.

|Aug 27, 2026
Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.

|Aug 17, 2026
Postoperative Complications Associated with Advanced Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

|Jul 16, 2026
Real-world outcomes of subcutaneous infliximab in a Middle Eastern inflammatory bowel disease cohort: a prospective study of switch and de novo treatment strategies.

Pageof 3

Frequent Collaborators

3 joint publications

Badr Al-Bawardy

3 joint publications

Badr Al-Bawardy

2 joint publications

Palak J Trivedi

2 joint publications

Tine Jess

Mohammed Nabil Quraishi - Author Profile | JoVE Visualize